Board meeting scheduled for May 5, 2026 to consider audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
Board to evaluate proposal for raising funds through issuance of non-convertible debentures subject to regulatory approvals.
Trading window closure for securities remains in effect until May 7, 2026, as per insider trading regulations.